MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Stock Cash Flow
NASDAQ:MLTX - Nasdaq - KY61559X1045 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -147.83M | -121.24M | -44.08M | -64.51M | -53.64M | |||
| Depreciation Amortization | 1.74M | 1.38M | 13.20K | 10.00K | 0.00 | |||
| Change In Working Capital | -1.31M | -3.78M | -6.22M | -1.43M | 4.48M | |||
| Taxes Paid | N/A | 147.30K | 41.70K | N/A | N/A | |||
| Other non cash items | 7.62M | 7.06M | 7.51M | 10.03M | 13.98M | |||
| OPERATING CASH FLOW | -139.78M | -116.59M | -42.78M | -55.89M | -35.18M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -342.70K | -519.50K | -284.60K | -20.00K | -50.00K | |||
| Other Investing Activity | -120.20M | -205.08M | -24.90M | -32.32M | N/A | |||
| INVESTING CASH FLOW | -120.55M | -205.60M | -25.18M | -32.34M | -50.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | -15.00M | 15.00M | |||
| Stock Issued/Repurchased | 342.00K | 52.78M | 482.45M | 50.00K | 28.26M | |||
| Other Financing Activity | 91.80K | -1.47M | -2.75M | 134.65M | 0.00 | |||
| FINANCING CASH FLOW | 73.46M | 51.31M | 479.70M | 119.69M | 43.26M | |||
| Exchange Rate Effect | -6.50K | 128.00K | -75.30K | 10.00K | 0.00 | |||
| CHANGE IN CASH | -186.87M | -270.74M | 411.66M | 31.47M | 8.03M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -139.78M | -116.59M | -42.78M | -55.89M | -35.18M | |||
| Capital Expenditure | -342.70K | -519.50K | -284.60K | -20.00K | -50.00K | |||
| FREE CASH FLOW | -140.12M | -117.11M | -43.06M | -55.91M | -35.23M | |||
All data in USD